alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)

Term ID

CHEBI:142351

Synonyms

Ac-O-9-GT3(d18:0)(3-)
alpha-9-O-Ac-NeuNAc-(2->8)-alpha-NeuNAc-(2->8)-alpha-NeuNAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)(3-)
alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine(3-)
ganglioside Ac-O-9-GT3 (d18:0)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-) organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-) organic molecular entity Show first 5 Terms

Phenotype

Phenotype resulting from alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)

Phenotype where environments contain alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)

Phenotype modified by environments containing alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)

Human Disease / Model Data

Citations